Lubeluzole in Ischemic Stroke "LUB-INT-13"

Completed

Phase 3 Results

Summary of Purpose

To determine the safety and efficacy of lubeluzole in treating acute stroke with an 8-hour inclusion time window.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Janssen Research Foundation.

Trial Design

Phase III international, multi-center, placebo-controlled trial of 1786 patients.

Contacts

Not available